Disposable Syringe Markets

Content

• 1. Introduction
  • 1.1 Statement of Report
  • 1.2 About this Report
  • 1.3 Scope of the Report
  • 1.4 Objectives
  • 1.5 Methodology
  • 1.6 Executive Summary
• 2. Disposable Syringe Markets
  • 2.1 Overview
  • 2.2 Infection Control and Safety
    • 2.2.1 Needlestick Injuries
    • 2.2.2 Availability of Safety Syringes in the U.S. Healthcare Facilities
  • 2.3 Cost of Safety Syringe
  • 2.4 Market Expansion
  • 2.5 Unsafe Injection Practices
  • 2.6 Hospital Consolidations Pressure Companies to Reduce Prices
  • 2.7 Strategic Alliance of Needleless Injector Manufacturers
  • 2.8 Technological Advancements in Disposable Syringes
    • 2.8.1 Reconstitution inside Sterile Syringes
    • 2.8.2 Plungerless Prefilled Syringes
    • 2.8.3 The Disposable UniJect
  • 2.9 Award Winning Syringes
    • 2.9.1 Episure AutoDetect Epidural Syringe
    • 2.9.2 ConfiDose Disposable Autoinjector
    • 2.9.3 Humatrope Reconstitution Device
    • 2.9.4 Vasceze Plungerless Syringe
• 3. Disposable Syringe Market Segments
  • 3.1 Overview
    • 3.1.1 World Market for Disposable Syringes
    • 3.1.2 U.S. Market for Disposable Syringes
    • 3.1.3 Disposable Syringe Market in India
• 4. Insulin Syringes
  • 4.1 Insulin Strengths: U-40 and U-100
  • 4.2 Market for Insulin Pen
  • 4.3 Shelf Life of Insulin Pen Cartridges
  • 4.4 An Update on Insulin Injection Devices
    • 4.4.1 Insulin Injection Devices Currently Available in the U.S
    • 4.4.2 Disposable Pens
    • 4.4.3 Refillable Pens
    • 4.4.4 Pen Needles
    • 4.4.5 Benefits and Patient Preferences
    • 4.4.6 Disadvantages of Pen Syringes
    • 4.4.7 Insulin Pens and the Hospital Bills
  • 4.5 Insulin Pens for Indian Market from IDC
  • 4.6 Expansion of Facilities for Insulin Pens by Eli Lilly and Rexam
  • 4.7 Major Players in Insulin Pens and Syringes
    • 4.7.1 Sanofi-Aventis
      • 4.7.1.1 Sanofi-Aventis Business in Diabetes Care Segment
    • 4.7.2 Novo Nordisk
      • 4.7.2.1 Novo Nordisks Diabetes Care Business in North America
      • 4.7.2.2 Novo Nordisks International Operations
      • 4.7.2.3 Novo Nordisks Business in Diabetes Care in Europe
    • 4.7.3 Eli Lilly & Co
      • 4.7.3.1 Byetta
      • 4.7.3.2 Humulin
      • 4.7.3.3 Humalog
• 5. Safety Syringes
  • 5.1 Available Safety Syringe Technologies
    • 5.1.1 Retrofitted Syringes
    • 5.1.2 Automatically Retractable Syringes
    • 5.1.3 Manually Retractable Syringes
  • 5.2 Safety Syringe Market
  • 5.3 Drivers of Safety Syringes
• 6. Prefilled Syringes
  • 6.1 Types of Prefilled Syringes (PFS)
  • 6.2 Market for Prefilled Syringes
  • 6.3 The Rise of Prefilled Syringes
  • 6.4 Needle Safety for Prefilled Syringes
    • 6.4.1 V-OVS NS
    • 6.4.2 Preventis
    • 6.4.3 UltraSafe Passive Delivery System/ERYPROSafe and NUFILSafe
  • 6.5 Sterility Maintenance of Prefilled Syringes
  • 6.6 Compatibility of Drugs with the Components of Prefilled Syringes
  • 6.7 Some of the Drugs Available in Prefilled Syringes
    • 6.7.1 Ovidrel PreFilled Syringe
    • 6.7.2 Enbrel Prefilled Syringes
    • 6.7.3 Biocons Prefilled Safety Syringes
    • 6.7.4 Relistor Prefilled Syringes
    • 6.7.5 PEGASYS
    • 6.7.6 Afluria
    • 6.7.7 Enzira
    • 6.7.8 FluZone Prefilled Syringe for Children
    • 6.7.9 Novolin N FlexPen Prefilled Insulin Syringe
    • 6.7.10 NovoLog Insulin Prefilled Syringe
    • 6.7.11 GlaxoSmithKlines Vaccines in Prefilled Syringes
  • 6.8 U.S. Production of Unilifes Prefilled Syringes
  • 6.9 Some of the Major Providers of Syringe-Prefilling Services and Products
    • 6.9.1 Althea Technologies, Inc
      • 6.9.1.1 Altheas Clinical Manufacturing
      • 6.9.1.2 Altheas Fill/Finish Services
      • 6.9.1.3 Altheas Contract Manufacturing
    • 6.9.2 Baxter International, Inc
      • 6.9.2.1 Baxters Contract Manufacturing
      • 6.9.2.2 Baxters Fill and Finish Capabilities
      • 6.9.2.3 Baxters Prefilled Syringes Capability
      • 6.9.2.4 Baxters Vials
      • 6.9.2.5 Baxters Cartridges
    • 6.9.3 Becton, Dickinson and Company
      • 6.9.3.1 BDs Prefilled Syringe Services
      • 6.9.3.2 BD Hypak SCF Glass Prefillable Syringes
      • 6.9.3.3 BD Sterifill SCF Plastic Prefillable Syringe Systems
      • 6.9.3.4 BD Physioject Disposable AutoInjector
      • 6.9.3.5 BD MicroInfusor Automatic Injection System
      • 6.9.3.6 BD Liquid Dry Injector Disposable Pen Injector
      • 6.9.3.7 BD Pens Customized Self-Injection Systems
      • 6.9.3.8 BD Soluvia Prefillable Microinjection System
      • 6.9.3.9 BD Preventis Shielding System for Prefilled Syringes
    • 6.9.4 Catalent Pharma Solutions, Inc
      • 6.9.4.1 The Protector Safety Shield System
      • 6.9.4.2 The ASI Autoinjector and Ultra-Compact ASI Mini Autoinjector
    • 6.9.5 Hyaluron Contract Manufacturing (HCM)
      • 6.9.5.1 Hyalurons Syringe Filling
    • 6.9.6 Vetter Pharma Fertigung GmbH
  • 6.10 Features of Prefilled Syringes
    • 6.10.1 Dual Chamber Prefilled Syringes
• 7. Pen Syringes
  • 7.1 Pen Devices for Insulin Delivery
  • 7.2 Technical Advances in Insulin Pens
  • 7.3 Pen Types and Styles
  • 7.4 Prefilled Pens
  • 7.5 Reusable Pens
  • 7.6 Prefilled Autoinjecting Disposable Syringes
  • 7.7 Uniject Injection Device
• 8. Microneedle
  • 8.1 Electronic Mosquito
• 9. Needle-free Injectors
  • 9.1 Needle-free Delivery of Liquids
  • 9.2 Needle-free Delivery of Solid Formulations
  • 9.3 Needleless Injector from Injex
  • 9.4 Jet Syringe from Injex
  • 9.5 Syrijet
  • 9.6 PenJet
  • 9.7 Needle-free Injector for Human Growth Hormone
• 10. Needle and Syringe Market Trends
  • 10.1 Market Segments
  • 10.2 Customer Needs
  • 10.3 Competitor Analysis
    • 10.3.1 Automatic Safety Syringes
    • 10.3.2 Manually Locking Safety Syringes
  • 10.4 Third Party Reimbursement
  • 10.5 Regulation
  • 10.6 Drug Discovery Trends
  • 10.7 Demographic Shifts
  • 10.8 Growth in Home Healthcare
• 11. Technological Developments
  • 11.1 Auto-Disable Syringes
    • 11.1.1 AD Syringes with Needle Retraction/Disposal Feature
    • 11.1.2 AD Syringe with No Needle Retraction Feature
    • 11.1.3 Needlestick Prevention Syringes
    • 11.1.4 Automatic Needlestick Prevention Feature
      • 11.1.4.1 UltraSafePassive Delivery System
      • 11.1.4.2 Sterimatic Sleeve
      • 11.1.4.3 K3 Safety Cap
  • 11.2 Manual Needlestick Prevention Feature
    • 11.2.1 Safety Lok Syringe
    • 11.2.2 MonojectMagellan
• 12. Business Trends
  • 12.1 Market Drivers
  • 12.2 Market Prospects
  • 12.3 Marketing and Distribution
  • 12.4 Competitive Landscape
  • 12.5 Future Technologies
    • 12.5.1 Glide Solid Dose Injector (SDI)
    • 12.5.2 BD Physioject
• 13. Regulatory Measures
  • 13.1 Safety Syringes in Europe
• 14. Company Profiles
  • 14.1 Abbott Laboratories
    • 14.1.1 HUMIRA Prefilled Syringe
    • 14.1.2 HUMIRA Pen
    • 14.1.3 Precision Sure-Dose Insulin Syringes
  • 14.2 Albert David Limited
  • 14.3 Alshifa Medical Syringes Manufacturing Company Ltd
  • 14.4 Althea Technologies, Inc
  • 14.5 Avitro, Inc
  • 14.6 Baxter International, Inc
    • 14.6.1 Baxters Medication Delivery
    • 14.6.2 Baxters IV Therapies
    • 14.6.3 Baxters Global Injectables
    • 14.6.4 Baxters Infusion Systems
    • 14.6.5 Baxters IV Infusion Pumps and Infusion Sets
    • 14.6.6 Baxters Pharma Partnering
  • 14.7 Becton, Dickinson and Company (BD)
    • 14.7.1 BDs Role in Designing Devices for Safe and Effective Injections and Infusions
    • 14.7.2 BDs Products
  • 14.8 Boston Scientific Corporation
  • 14.9 B. Braun
    • 14.9.1 The Hospital Care Division
    • 14.9.2 The Aesculap Division
    • 14.9.3 The Out Patient Market (OPM) Division
    • 14.9.4 The B. Braun Avitum Division
    • 14.9.5 B. Brauns Syringe Products
  • 14.10 Bioject Medical Technologies, Inc
    • 14.10.1 Biojector 2000
    • 14.10.2 Drug Reconstitution System
    • 14.10.3 Vitajet
    • 14.10.4 Cool.click
    • 14.10.5 SeroJet
  • 14.11 Catalent Pharma Solutions, Inc
    • 14.11.1 Catalents Oral Technologies Segment
    • 14.11.2 Catalents Sterile Technologies Segment
    • 14.11.3 Catalents Packaging Services Segment
    • 14.11.4 Catalents Manufacturing Capabilities
    • 14.11.5 Catalents Employee Strength
    • 14.11.6 Catalents Syringes
  • 14.12 C.R. Bard, Inc
    • 14.12.1 Bards Vascular Business
    • 14.12.2 Bards Urology Business
    • 14.12.3 Bards Oncology Business
    • 14.12.4 Bards Business in Surgical Specialties
    • 14.12.5 Bards Overseas Expansion
    • 14.12.6 Bards Bulb Syringes and Trays
    • 14.12.7 Bards Piston Syringes and Trays
  • 14.13 Coeur, Inc
    • 14.13.1 Angiographic Syringes from Coeur, Inc
    • 14.13.2 CT Syringes from Coeur, Inc
  • 14.14 Covidien Ltd
    • 14.14.1 Covidiens Medical Devices Segment
    • 14.14.2 Covidiens R&D
    • 14.14.3 Covidiens Competitors in Medical Devices
    • 14.14.4 Covidiens Syringes
  • 14.15 Henke-Sass, Wolf GmbH
    • 14.15.1 Two-Part Disposable Syringes 1-50(60) ml
    • 14.15.2 Three-Part Disposable Syringes 1-30 ml
    • 14.15.3 Disposable Needles HSW FINE-JECT
  • 14.16 Hindustan Syringes & Medical Devices, Ltd. (HMD)
    • 14.16.1 Insulin Syringes from HMD
    • 14.16.2 HMDs Single Use Needles
    • 14.16.3 HMDs Single Use Syringes
  • 14.17 Hi-Tech Medical Products Ltd
  • 14.18 Hyaluron Contract Manufacturing
    • 14.18.1 HCMs Major Markets
    • 14.18.2 HCMs Facility
  • 14.19 International Medication System Ltd
    • 14.19.1 Delivery Systems from IMS
    • 14.19.2 PCA Products from IMS
    • 14.19.3 Phytonadione Injection USP
    • 14.19.4 Lidocaine HCl Jelly, USP 2% (Preservative-free)
  • 14.20 Life-Shield Products, Inc
  • 14.21 Merit Medical Systems, Inc
    • 14.21.1 Merits Products
    • 14.21.2 Merits Vascular Access Products
    • 14.21.3 Merits Business in the U.S
    • 14.21.4 Merits International Business
    • 14.21.5 Merits Customers
    • 14.21.6 Merits R&D
    • 14.21.7 Merits Manufacturing Facilities
  • 14.22 Milestone Scientific
    • 14.22.1 Milestone Scientifics Product Platform
    • 14.22.2 Milestone Scientifics Investment in R&D
    • 14.22.3 Milestone Scientifics Business Performance
  • 14.23 Novo Nordisk A/S
    • 14.23.1 Novo Nordisks Business in Diabetes Care Segment
    • 14.23.2 Novo Nordisks Modern Insulins, Human Insulins and Insulin-related Products
    • 14.23.3 Novo Nordisks Geographic Performance in Diabetes Care Products
    • 14.23.4 Pipeline Progress in Nova Nordisk
    • 14.23.5 Novo Nordisks Modern Insulin Portfolio
  • 14.24 Owen Mumford Ltd
    • 14.24.1 Owen Mumfords Global Locations
    • 14.24.2 Owen Mumfords Products
  • 14.25 Plas-Pak Industries, Inc
    • 14.25.1 Dial-A-Dose Disposable Veterinary Syringes
    • 14.25.2 Dual Syringe and Dental Syringe from Plas-Pak
    • 14.25.3 Mini Dual Syringe
    • 14.25.4 Manual Dual Syringes
  • 14.26 Retractable Technologies, Inc
    • 14.26.1 Retractable Technologies Principal Products
    • 14.26.2 Retractable Technologies Principal Markets
    • 14.26.3 Retractable Technologies R&D
    • 14.26.4 Retractable Technologies VanishPoint Products
  • 14.27 Revolutions Medical Corporation
    • 14.27.1 Rev Vac Safety Syringe
  • 14.28 Safety Syringes, Inc
    • 14.28.1 Custom Engineering from Safety Syringes, Inc
    • 14.28.2 Syringe Products from Safety Syringes, Inc
  • 14.29 Smiths Medical International/Medex, Inc
    • 14.29.1 Smiths Medicals Markets
    • 14.29.2 Smiths Medicals Medication Delivery Segment
    • 14.29.3 Smiths Medicals Vital Care Segment
    • 14.29.4 Smiths Medicals Safety Devices Segment
    • 14.29.5 Smiths Medicals Business Performance
    • 14.29.6 Smiths Medicals Business Performance on Geographic Basis
    • 14.29.7 Smiths Medicals R&D
    • 14.29.8 Syringes from Smiths Medicals
  • 14.30 Specialized Health Products International, Inc
    • 14.30.1 SHPIs Products and Services
    • 14.30.2 SHPIs Licensed Products
  • 14.31 Star Syringe Ltd
    • 14.31.1 Star Alliances
    • 14.31.2 Preoducts from Star Syringe Ltd
  • 14.32 Terumos Medical Corporation
    • 14.32.1 Terumos General Hospital Products
    • 14.32.2 Terumos Diabetes Care Products
    • 14.32.3 Terumos Syringe Products
  • 14.33 UltiMed, Inc
    • 14.33.1 UltiCare Insulin Syringes
    • 14.33.2 UltiCare Pen Needles
  • 14.34 Unilife Medical Solutions, Ltd
    • 14.34.1 Pharmaceutical Market for Unilifes Prefilled Syringes
    • 14.34.2 Unilife Partnership with Sanofi-Aventis
    • 14.34.3 Unilifes Licensing Agreement with Sanofi-Aventis
    • 14.34.4 Unilifes Partnership with Gerresheimer Bnde
    • 14.34.5 Unilifes Portfolio of Safety Syringes
    • 14.34.6 Unilifes Prefilled Syringes
    • 14.34.7 Unilifes Contract Manufacturing Activities
    • 14.34.8 Unilifes Performance in Syringe Market
  • 14.35 Vetter Pharma-Fertigung GmbH & Co., KG
    • 14.35.1 Vetter Services and Solutions
    • 14.35.2 Dual-Chamber Technology
  • 14.36 Vita Needle Company, Inc
    • 14.36.1 Disposable Stainless Steel Needle Blunts from Vita Needle
    • 14.36.2 Teflon Dispensing Needles
    • 14.36.3 Vita Needles Polypropylene Needles
    • 14.36.4 Vita Needles Taper Tip Needles
  • 14.37 West Pharmaceutical Services, Inc
    • 14.37.1 Wests Pharmaceutical Systems Segment
    • 14.37.2 Wests Tech Group Segment
    • 14.37.3 Wests R&D Activities
    • 14.37.4 Wests Syringe Products
  • 14.38 Wuxi Yushou Medical Appliances Co., Ltd
  • 14.39 Ypsomed Holding AG
    • 14.39.1 Ypsomeds Injection Systems
    • 14.39.2 Ypsomeds Insulin Delivery Systems
    • 14.39.3 Additional Indication Areas for Pen Systems
    • 14.39.4 Ypsomeds Innovative Injection Systems at a Glance
    • 14.39.5 Ypsomeds Complete Product Range for Insulin Suppliers
    • 14.39.6 Ypsomeds New Dual-Chamber Injecting Systems
    • 14.39.7 Ypsomeds ServoPen
    • 14.39.8 Growth of Ypsomeds Pen Needles
    • 14.39.9 Ypsomeds Performance in 2008/2009
    • 14.39.10 Ypsomeds R&D
  • 14.40 The Medical House PLC (TMH)
    • 14.40.1 TMHs Products
  • Appendix 1: U.S. Healthcare Expenditure Projections, 2008-2018
  • Appendix 2: Syringe Needle Terminology
  • Appendix 3: Medication Errors and Syringe Safety
  • Appendix 3.1: Injectable Medication Errors
  • Appendix 3.2: Frequency of Syringe Usage
  • Appendix 3.3: Labeling Injectable Medications
  • Appendix 3.4: Challenges of Labeling
  • Appendix 3.5: Benefits of a Write-On Stripe
  • Appendix 3.6: Nurses Influence on Selection of Sharp Devices
  • Appendix 3.7: Needlestick Injuries
  • Appendix 3.8: Prevention of Needlestick Injuries
  • Appendix 3.9: Protection from Needlestick Injuries
• INDEX OF FIGURES
  • Figure 2.1: Principal Causes of Needlestick Injuries
  • Figure 2.2: Availability of Safety Syringes in the U.S. Healthcare Facilities, 2008
  • Figure 3.1: Worldwide Unit Market for Syringes and Needles, 2004-2012
  • Figure 3.2: Global Syringe Market, 2009
  • Figure 3.3: Worldwide Market for Disposable Syringes and Needles, 2004-2012
  • Figure 3.4: U.S. Market for Disposable Syringes and Needles, 2006-2013
  • Figure 3.5: Market Segments of the U.S. Syringe Market, 2009
  • Figure 3.6: E.U. Market for Syringes, Needles and Catheters, 2007 and 2008
  • Figure 3.7: Worldwide Market Share for Hypodermic Syringes, 2009
  • Figure 3.8: Disposable Syringe Market in India, 2008-2012
  • Figure 3.9: Market Share for Disposable Syringes in India, 2008
  • Figure 3.10: Market Share for Disposable Needles in India, 2008
  • Figure 4.1: Market Growth for Insulin Pen, 2007-2014
  • Figure 4.2: Market Growth for Insulin Pens in Europe, 2007-2014
  • Figure 4.3: Global Sales Performance of Sanofi-Aventis Lantus, 2007 and 2008
  • Figure 4.4: Global Sales Performance of Sanofi-Aventis Amaryl, 2007 and 2008
  • Figure 4.5: Sales Performance of Sanofi-Aventis Lantus by Geography, 2008
  • Figure 4.6: Novo Nordisks Business Performance in Diabetes Care by Geography, 2008
  • Figure 4.7: Novo Nordisks Performance in Diabetes Care, 2004-2008
  • Figure 4.8: Eli Lillys Business Performance in Byetta, 2006 and 2007
  • Figure 4.9: Eli Lillys Business Performance in Humulin, 2006-2008
  • Figure 4.10: Eli Lillys Sales Performance in Humalog, 2006-2008
  • Figure 5.1: Growth of Safety Syringe Market, 2008-2012
  • Figure 6.1: Market Growth for Prefilled Syringes, 2009-2013
  • Figure 6.2: Growth of Prefilled Syringes Market in E.U., 2008-2012
  • Figure 10.1: Breakdown of U.S. Syringe Market, 2009
  • Figure 10.2: U.S. Home Healthcare Products Market, 2007-2012
  • Figure 14.1: Abbotts Global Business Performance by Country, 2008
  • Figure 14.2: Abbotts Global Business Performance, 2004-2008
  • Figure 14.3: Baxters Performance in Medication Delivery Segment, 2008
  • Figure 14.4: Baxters Performance in IV Therapies, 2006-2008
  • Figure 14.5: Baxters Performance in Injectables, 2006-2008
  • Figure 14.6: Baxters Performance in Infusion Systems, 2006-2008
  • Figure 14.7: BDs Performance in Safety-engineered Devices, 2007 and 2008
  • Figure 14.8: BDs International Performance in Safety-engineered Devices, 2007 and 2008
  • Figure 14.9: Business Performance by B. Brauns Hospital Care Division, 2006-2008
  • Figure 14.10: Business Performance by B. Brauns Aesculap Division, 2006-2008
  • Figure 14.11: Business Performance by B. Brauns Out Patient Market Division, 2006-2008
  • Figure 14.12: Business Performance by B. Brauns Avitum Division, 2006-2008
  • Figure 14.13: B. Brauns Business Performance by Geographic Region, 2008
  • Figure 14.14: Share of Biojects Business with its Prominent Customers, 2007
  • Figure 14.15: Biojects Business Performance by Product Line, 2007
  • Figure 14.16: Biotechs Business Performance in the U.S. and Other Countries, 2007
  • Figure 14.17: Catalents Business Performance, 2004-2008
  • Figure 14.18: Catalents Business Performance in its Oral Technologies Segment, 2007 and 2008
  • Figure 14.19: Catalents Business Performance in its Sterile Technologies Segment, 2007 and 2008
  • Figure 14.20: Catalents Business Performance in its Packaging Services Segment, 2007 and 2008
  • Figure 14.21: Catalents Employee Strength by Region, 2008
  • Figure 14.22: Bards Business Performance in its Vascular Segment, 2004-2008
  • Figure 14.23: Bards Business Performance in its Urology Segment, 2004-2008
  • Figure 14.24: Bards Business Performance in its Oncology Segment, 2004-2008
  • Figure 14.25: Bards Business Performance in its Surgical Specialties Segment, 2004-2008
  • Figure 14.26: Business Performance of Covidiens Medical Device Segment, 2006-2008
  • Figure 14.27: Covidiens Investment in R&D, 2006-2008
  • Figure 14.28: Covidiens Business Performance in Syringes (Sharp Safety Products), 2006-2008
  • Figure 14.29: Merits Business Performance, 2004-2008
  • Figure 14.30: Merits Investment in R&D, 2004-2008
  • Figure 14.31: Milestone Scientifics Investment in R&D, 2007 and 2008
  • Figure 14.32: Milestone Scientifics Domestic Business Performance, 2007 and 2008
  • Figure 14.33: Milestone Scientifics International Business Performance, 2007 and 2008
  • Figure 14.34: Novo Nordisks Sales Performance of Diabetes Care Products, 2004-2008
  • Figure 14.35: Novo Nordisks Sales Performance in Modern Insulins (Insulin Analogues), 2004-2008
  • Figure 14.36: Retractable Technologies Business Performance, 2004-2008
  • Figure 14.37: Retractable Technologies Domestic Business Performance, 2006-2008
  • Figure 14.38: Retractable Technologies International Business Performance, 2006-2008
  • Figure 14.39: Retractable Technologies Investment in Research and Expenditure, 2006-2008
  • Figure 14.40: Smiths Medicals Business Performance, 2007 and 2008
  • Figure 14.41: Smiths Medicals Business Performance by Segment, 2007
  • Figure 14.42: SHPIs Sales Performance, 2006 and 2007
  • Figure 14.43: SHPIs Revenue from Royalties, 2006 and 2007
  • Figure 14.44: Terumos Business Performance in Prefilled Syringes, 2005-2007
  • Figure 14.45: Terumos Business Performance in Diabetes Care, 2003-2007
  • Figure 14.46: Wests Business Performance in Pharmaceutical Systems Segment, 2006-2008
  • Figure 14.47: Wests Business Performance in Tech Group Segment, 2006-2008
  • Figure 14.48: Wests Investment in R&D in Pharmaceutical Systems Segment, 2006-2008
  • Figure 14.49: Wests Investment for R&D in Tech Group Segment, 2006-2008
  • Figure 14.50: Global Prevalence of Diabetes, 2008-2025
  • Figure 14.51: Prevalence of Diabetes in India, 2008-2025
  • Figure 14.52: Prevalence of Diabetes in China, 2008-2025
  • Figure 14.53: Ypsomeds Sales Performance, 2006/2007 and 2008/2009
  • Figure 14.54: Ypsomeds Sales Performance by Geography, 2008/2009
  • Figure 14.55: Ypsomeds R&D Expenditure, 2006/2007 and 2008/2009
  • Figure 14.56: TMHs Business Performance, 2006-2008
  • Figure 14.57: TMHs Business Performance by Geography, 2008
  • Figure A1.1: National Health Expenditure in the U.S., 2009-2014
  • Figure A1.2: National Health Expenditure as a Percent of GDP, 2009-2014
  • Figure A1.3: Health Expenditure Per Capita, 2009-2014
  • Figure A1.4: Home Healthcare Expenditure, 2009-2014
  • Figure A1.5: Prescription Drug Expenditure, 2009-2014
  • Figure A1.6: Other Non-Durable Medical Products Expenditure, 2009-2014
  • Figure A1.7: Nursing Home Care Expenditure, 2009-2014
  • Figure A1.8: Dental Service Expenditure, 2009-2014
  • Figure A1.9: Hospital Care Expenditure, 2009-2014
  • Figure A1.10: Physician and Clinical Services Expenditure, 2009-2014
  • Figure A1.11: Personal Healthcare Expenditure, 2009-2014
  • Figure A3.1: Timing of Needlestick Injuries
• INDEX OF TABLES
  • Table 4.1: Shelf Life of Insulin Pen Cartridges
  • Table 4.2: Major Insulin Pen Devices Currently Available in the U.S., 2008
  • Table 10.1: Highlights of Several Leaders in the Disposable Safety Syringe Market
  • Table 14.1: Albert Davids Syringes with Needles, 2009
  • Table 14.2: Albert Davids Needles, 2009
  • Table 14.3: BDs Auto-Disable Syringes
  • Table 14.4: Insulin Syringes from BD, 2009
  • Table 14.5: BDs Allergy Syringes
  • Table 14.6: BDs Tuberculin Syringes
  • Table 14.7: BDs Syringes and Needles (Sterile, Single-Use)
  • Table 14.8: BDs Safety-Lok Safety-Syringes
  • Table 14.9: BDs SafetyGlide Syringes
  • Table 14.10: BDs Eclipse Syringes
  • Table 14.11: BDs Integra Syringes
  • Table 14.12: BDs PosiFlush Prefilled Syringes
  • Table 14.13: Bards Piston Syringes and Trays, 2009
  • Table 14.14: Bards Bulb Syringes and Trays, 2009
  • Table 14.15: Angiographic Syringes from Coeur, Inc., 2009
  • Table 14.16: CT Syringes from Coeur, Inc., 2009
  • Table 14.17: HMDs Dispovan Insulin Syringes, 2009
  • Table 14.18: HMDs Single Use Needles, 2009
  • Table 14.19: HMDs Single Use Syringes, 2009
  • Table 14.20: Hi-Tech Single-Use Syringes, 2009
  • Table 14.21: Hi-Techs Single Use Insulin Syringes, 2009
  • Table 14.22: HCMs Contract Manufacturing Categories, 2009
  • Table 14.23: Syringes from IMS, 2009
  • Table 14.24: PCA Syringe from IMS, 2009
  • Table 14.25: Phytonadione Injection USP from IMS, 2009
  • Table 14.26: Lidocaine Prefilled Syringes from IMS, 2009
  • Table 14.27: Life-Shields Syringe Products, 2008
  • Table 14.28: Autopen Products from Owen Mumford, 2008
  • Table 14.29: Unifine Products from Owen Mumford, 2008
  • Table 14.30: Autoject Products from Owen Mumford, 2008
  • Table 14.31: Retractable Technologies VanishPoint Syringes, 2009
  • Table 14.32: Smiths Pro Fixed Needle TB Syringe, 2009
  • Table 14.33: Smiths Needle-Pro Needle with Needle Protection Device
  • Table 14.34: Smiths Needle-Pro Syringe and Needle with Needle Protection Device, 2009
  • Table 14.35: Smiths Needle-Pro Needle Protection Device for Insulin Injections, 2009
  • Table 14.36: Smiths Needle-Pro Fixed Needle Insulin Syringe
  • Table 14.37: SurGard2 Syringes with Safety Needle, 2009
  • Table 14.38: Terumos SurGuard2 Safety Needles, 2009
  • Table 14.39: Terumos Hypodermic Needles, 2009
  • Table 14.40: Terumos Hypodermic Syringes without Needle, 2009
  • Table 14.41: Terumos Tuberculin Syringes, 2009
  • Table 14.42: Terumos Hypodermic Syringes with Needle
  • Table 14.43: Terumos SurSaver 1 cc Syringes with Low Dead Space, 2009
  • Table 14.44: Terumos Dental Needles, 2009
  • Table 14.45: Terumos Spinal Needles, 2009
  • Table 14.46: Terumos SurGuard Safety Insulin Syringes, 2009
  • Table 14.47: Terumos Insulin Syringes, 2009
  • Table 15.48: Thinpros Insulin Syringes, 2009
  • Table 15.49: UltiMeds UltiCare Insulin Syringes, 2009
  • Table 14.50: UltiCare Pen Needles, 2009
  • Table 14.51: Vita Needles Stainless Steel Needle Blunts, 2009
  • Table 14.52: Vita Needles Teflon Dispensing Needles, 2009
  • Table 14.53: Vita Needles Polypropylene Needles, 2009
  • Table 14.54: Vita Needles Taper Tip Needles, 2009
  • Table 14.55: Ypsomeds Product Roadmap, 2009-2013
  • Table 14.56: Ypsomeds Innovative Platforms